Abstract
Annals of the New York Academy of SciencesVolume 448, Issue 1 p. 553-561 Cholecystokinin-mediated Synaptic Function and the Treatment of Neuropsychiatric Disease T. N. CHASE, T. N. CHASE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorP. BARONE, P. BARONE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorG. BRUNO, G. BRUNO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. L. COHEN, S. L. COHEN Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJ. JUNCOS, J. JUNCOS Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorM. KNIGHT, M. KNIGHT Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. RUGGERI, S. RUGGERI Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorL. STEARDO, L. STEARDO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorC. A. TAMMINGA, C. A. TAMMINGA Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author T. N. CHASE, T. N. CHASE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorP. BARONE, P. BARONE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorG. BRUNO, G. BRUNO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. L. COHEN, S. L. COHEN Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJ. JUNCOS, J. JUNCOS Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorM. KNIGHT, M. KNIGHT Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. RUGGERI, S. RUGGERI Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorL. STEARDO, L. STEARDO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorC. A. TAMMINGA, C. A. TAMMINGA Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author First published: July 1985 https://doi.org/10.1111/j.1749-6632.1985.tb29948.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume448, Issue1Neuronal CholecystokininJuly 1985Pages 553-561 RelatedInformation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
